17- nor-Cephalotane-Type Diterpenoids from Cephalotaxus fortunei

Area of Science:

• Natural Product Chemistry
• Organic Chemistry
• Pharmacology

Background:

• Cephalotaxus fortunei var. alpine seeds are a source of complex natural products.
• Diterpenoids represent a diverse class of plant-derived compounds with potential biological activities.

Purpose of the Study:

• To isolate and characterize new 17-nor-cephalotane-type diterpenoids from Cephalotaxus fortunei var. alpine.
• To determine the absolute configuration of known compounds and revise structures.
• To evaluate the cytotoxic activities of the isolated compounds.

Main Methods:

• Isolation and purification of compounds using chromatographic techniques.
• Structure elucidation via spectroscopic methods (NMR, MS) and X-ray crystallography.
• Cytotoxicity assays against A549 (lung cancer) and HL-60 (leukemia) cell lines.

Main Results:

• Seventeen new 17-nor-cephalotane-type diterpenoids, fortalpinoids A-Q (1-17), were identified.
• Compound 12 is the first 17-nor-cephalotane-type diterpenoid with an 8-oxabicyclo[3.2.1]oct-2-ene moiety.
• Absolute configuration of fortunolide A (18) determined; cephinoid Q structure revised to 14-epi-cephafortoid A (24).
• Several compounds demonstrated significant cytotoxicity against A549 and HL-60 cells.

Conclusions:

• The study expands the chemical diversity of 17-nor-cephalotane-type diterpenoids.
• The identified compounds, particularly fortalpinoids A-Q, show promising anticancer potential.
• Structure-activity relationship analysis provides a basis for further drug development efforts.